Suki Secures $90 Million in Funding to Enhance AI Capabilities
With its latest financing round, the company has increased its total funding raised to date to over $250 million.
AI-focused healthcare technology company Suki has raised $90 million in a Series E financing round to accelerate its growth and expand its AI capacity.
Details of the Funding Round
The Series E financing round organized by Suki was led by new investors Healthier Capital, Crosslink Capital, and Hercules Capital.
All existing institutional investors also supported this financing round, contributing to the company's growth targets.
Existing and New Partners
Existing institutional partners participating in the financing round include Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures.
As part of the investment agreement, Healthier Capital partner Aman Mahajan joined Suki's board of directors.
Areas of Resource Allocation
Suki Founder and CEO Punit Soni stated that the newly acquired capital will be used to advance artificial intelligence.
The company also plans to expand its commercial organization and scale its partner ecosystem.
Artificial Intelligence in the Healthcare Sector
Punit Soni emphasized that AI in healthcare goes beyond mere documentation to support clinical decisions.
It was stated that the technology improves financial performance and streamlines operations through a connected operating system.
Total Funding and Market Position
With this latest investment move, the company has raised a total of over $250 million in funding to date.
Suki currently continues to collaborate with more than 250 healthcare organizations.
New Technological Tools
The company recently launched a tool called Ask, which integrates the UpToDate Expert AI API solution owned by Wolters Kluwer.